Although our pCR analysis was limited by the low number of patients with this data available, these favorable pCR rates raise the intriguing possibility of the potential role of preopRT to increase pCR and as a tool of bioselection analogous to the emerging role that NACT plays in patients with hormone receptor-negative disease. This evidence concerns the gene NR4A1 and glycogen storage disease VI.